Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | STAT3 | P40763 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MITF | O75030 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28544589 | 0.90 | MEN1 (0.44) | TDP1SMN1; SMN2NPC1THRBRAB9A | |
| SCHEMBL29519256 | 0.90 | MEN1 (0.44) | TDP1SMN1; SMN2NPC1THRBRAB9A | |
| SCHEMBL29519640 | 0.90 | MEN1 (0.44) | TDP1SMN1; SMN2NPC1THRBRAB9A | |
| SCHEMBL16639653 | 0.90 | MEN1 (0.44) | TDP1SMN1; SMN2NPC1THRBRAB9A | |
| SCHEMBL29519181 | 0.90 | MEN1 (0.44) | TDP1SMN1; SMN2NPC1THRBRAB9A | |
| SCHEMBL16639658 | 0.90 | MEN1 (0.44) | TDP1SMN1; SMN2NPC1THRBRAB9A | |
| SCHEMBL16639652 | 0.90 | MEN1 (0.44) | TDP1SMN1; SMN2NPC1THRBRAB9A | |
| SCHEMBL16639654 | 0.90 | MEN1 (0.44) | TDP1SMN1; SMN2NPC1THRBRAB9A | |
| SCHEMBL2534629 | 0.90 | MEN1 (0.44) | TDP1SMN1; SMN2NPC1THRBRAB9A | |
| SCHEMBL29519320 | 0.90 | MEN1 (0.44) | TDP1SMN1; SMN2NPC1THRBRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260040695-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NEWSOUTH INNOVATIONS PTY LTD (AU) | 2026-02-05 | — | — | US | claimed |
| EP-4562077-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NewSouth Innovations Pty Limited (AU) | 2025-06-04 | — | — | EP | claimed |
| WO-2024020649-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NEWSOUTH INNOVATIONS PTY LIMITED (AU) | 2024-02-01 | — | — | WO | claimed |
| CN-115304757-B | Block type ink resin and preparation method thereof | 成都托展新材料股份有限公司 | 2023-08-11 | — | — | CN | claimed |
| WO-2022261721-A1 | HEALABLE AND REPROCESSABLE COMPOSITIONS | DEAKIN UNIVERSITY (AU) | 2022-12-22 | — | — | WO | claimed |
| CN-115304757-A | Block type ink resin and preparation method thereof | 成都托展新材料股份有限公司 | 2022-11-08 | — | — | CN | claimed |
| US-10551345-B2 | Poly and copoly(N-vinylamide)s and their use in capillary electrophoresis | APPLIED BIOSYSTEMS, LLC (US) | 2020-02-04 | — | — | US | claimed |
| EP-3000842-B1 | SURFACE MODIFICATION METHOD AND SURFACE MODIFICATION BODY | SUMITOMO RUBBER IND (JP) | 2019-11-06 | — | — | EP | claimed |
| EP-3127948-B1 | SURFACE MODIFICATION METHOD AND SURFACE-MODIFIED BODY | SUMITOMO RUBBER IND (JP) | 2018-11-14 | — | — | EP | claimed |
| US-20170356877-A1 | POLY AND COPOLY(N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS | APPLIED BIOSYSTEMS, LLC (US) | 2017-12-14 | — | — | US | claimed |
| US-20100051461-A1 | Poly and Copolyn(N-Vinylamide)s and their use in Capillary Electrophoresis | Life Technologies Corporation (US) | 2010-03-04 | — | — | US | claimed |
| EP-2053067-A1 | Poly and copoly (N-vinylamide)s and their use in capillary electrophoresis | Applied Biosystems Inc. (US) | 2009-04-29 | — | — | EP | claimed |
| EP-1636279-B1 | POLY AND COPOLY (N -VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS | APPLIED BIOSYSTEMS (US) | 2009-02-18 | — | — | EP | claimed |
| US-7329694-B2 | Ocular lens | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2008-02-12 | — | — | US | claimed |
| US-20070211130-A1 | Fusible inkjet recording element and related methods of coating and printing | EASTMAN KODAK COMPANY | 2007-09-13 | — | — | US | claimed |
| EP-1636279-A1 | POLY AND COPOLY (N -VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS | Applera Corporation (US) | 2006-03-22 | — | — | EP | claimed |
| US-20050025741-A1 | Copolymers with (meth)acrylamides; improved separation of polynucleotides | APPLIED BIOSYSTEMS, LLC | 2005-02-03 | — | — | US | claimed |
| WO-2004104054-A1 | POLY AND COPOLY (N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS | APPLERA CORPORATION (US) | 2004-12-02 | — | — | WO | claimed |
| US-20040191433-A1 | Ink-jet recording material | MITSUBISHI PAPER MILLS LIMITED (JP) | 2004-09-30 | — | — | US | claimed |
| WO-2002046759-A1 | DEVICE FOR CAPTURING A TARGET MOLECULE | BIO MERIEUX (FR) | 2002-06-13 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260040695-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | PIEZO1, LCP1, MTCL3 | TDP1 2457/4885SMN1; SMN2 531/4885NPC1 2063/4885 |
| US-20050025741-A1 | Copolymers with (meth)acrylamides; improved separation of polynucleotides | POLI, PCNA, POLL | TDP1 337/4885SMN1; SMN2 963/4885NPC1 4798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.